Holen Sie sich die Stockscreener-App
28.59
0.14%
0.04
Handel nachbörslich:
28.55
-0.04
-0.14%
Schlusskurs vom Vortag:
$28.55
Offen:
$28.44
24-Stunden-Volumen:
8,036
Relative Volume:
4.05
Marktkapitalisierung:
$N/A
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-9.01%
1M Leistung:
-11.66%
6M Leistung:
-9.70%
1J Leistung:
+4.73%
1-Tages-Spanne:
$28.30
$28.59
1-Wochen-Bereich:
$28.30
$31.23
52-Wochen-Spanne:
$27.38
$33.98
Franklin Genomic Advancements Etf Stock (HELX) Company Profile
Firmenname
Franklin Genomic Advancements Etf
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie HELX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| HELX | 28.59 | 0 | 0 | 0 | 0 | 0.00 |
| VTI | 291.50 | 417.53B | 0 | 0 | 0 | 0.00 |
| SPY | 588.14 | 372.57B | 0 | 0 | 0 | 0.00 |
| IVV | 591.07 | 253.41B | 0 | 0 | 0 | 0.00 |
| VB | 247.34 | 160.59B | 0 | 0 | 0 | 0.00 |
| QQQ | 500.01 | 124.43B | 0 | 0 | 0 | 0.00 |
Franklin Genomic Advancements Etf Aktie (HELX) Neueste Nachrichten
Trading (HELX) With Integrated Risk Controls - Stock Traders Daily
Trend Tracker for (HELX) - Stock Traders Daily
(HELX) Trading Advice - Stock Traders Daily
(HELX) On The My Stocks Page - Stock Traders Daily
2,250 Shares in CONSOL Energy Inc. (NYSE:CEIX) Purchased by Commonwealth Equity Services LLC - Defense World
(HELX) Technical Data - Stock Traders Daily
Where are the Opportunities in (HELX) - Stock Traders Daily
7 Best-Performing Biotech ETFs for July 2024 - NerdWallet
From AI drones to robots, this fund manager focuses on life-changing technology - MarketWatch
Learn to Evaluate (HELX) using the Charts - Stock Traders Daily
5 Best Performing Biotech ETFs in 2024 - Insider Monkey
ARK reveals the first European Ucits ETFs - RankiaPro En
Franklin Templeton Launches Franklin Focused Growth ETF (FFOG) - Yahoo Finance
12 Best Biotech ETFs To Buy - Yahoo Finance
Revvity (RVTY) Stock Price, News & AnalysisNYSE - MarketBeat
Franklin forges ahead with legal battle over gold ETF - Citywire
Revealed: The best-performing tech managers of Q2 - Citywire Selector
Franklin Templeton launches three thematic funds - Funds Europe Magazine
Technology Could Boost The NPV Of Biopharmaceutical Pipeline Assets Significantly - Seeking Alpha
5 ETFs Riding the Growth Comeback Euphoria - Yahoo Finance
How to Invest in Innovation - International Banker
Recursion Pharmaceuticals (RXRX) Stock Price, News & Analysis - MarketBeat
Robinhood Army Propels Thematic ETFs to a Record-Setting Year - Bloomberg
Franklin Templeton Gives Matt Moberg Three New Funds To Run - Investor's Business Daily
The Year of the Active ETF - Wealth Management
3 Genomics ETFs Worth Jumping For - Benzinga
Investing in Innovation - Wealth Management
Thematic ETFs need careful evaluation… - ETF Express
BioNTech (BNTX) Stock Price, News & Analysis - MarketBeat
Avantor (AVTR) Stock Price, News & Analysis - MarketBeat
Qiagen (QGEN) Stock Price, News & AnalysisNYSE - MarketBeat
Avid Bioservices (CDMO) Stock Price, News & Analysis - MarketBeat
Krystal Biotech (KRYS) Stock Price, News & Analysis - MarketBeat
Voyager Therapeutics (VYGR) Stock Price, News & Analysis - MarketBeat
Natera (NTRA) Stock Price, News & AnalysisNASDAQ - MarketBeat
Ionis Pharmaceuticals (IONS) Stock Price, News & Analysis - MarketBeat
Bio-Rad Laboratories (BIO) Stock Price, News & Analysis - MarketBeat
Bruker (BRKR) Stock Price, News & AnalysisNASDAQ - MarketBeat
Regeneron Pharmaceuticals (REGN) Stock Price, News & Analysis - MarketBeat
Ligand Pharmaceuticals (LGND) Stock Price, News & Analysis - MarketBeat
Vertex Pharmaceuticals (VRTX) Stock Price, News & Analysis - MarketBeat
Finanzdaten der Franklin Genomic Advancements Etf-Aktie (HELX)
Es liegen keine Finanzdaten für Franklin Genomic Advancements Etf (HELX) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.36%
Kapitalisierung:
|
Volumen (24h):